Champions Oncology Stock Options

CSBR Stock  USD 10.28  0.06  0.59%   
Champions Oncology's latest option contracts expiring on May 16th 2025 are carrying combined implied volatility of 1.5 with a put-to-call open interest ratio of 0.14 over 14 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on May 16th 2025.

Open Interest Against May 16th 2025 Option Contracts

The chart above shows Champions Oncology's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Champions Oncology's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Champions Oncology's option, there is no secondary market available for investors to trade.

In The Money vs. Out of Money Option Contracts on Champions Oncology

Analyzing Champions Oncology's in-the-money options over time can help investors to take a profitable long position in Champions Oncology regardless of its overall volatility. This is especially true when Champions Oncology's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Champions Oncology's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Champions Oncology's stock while costing only a fraction of its price.

Champions Oncology In The Money Call Balance

When Champions Oncology's strike price is surpassing the current stock price, the option contract against Champions Oncology stock is said to be in the money. When it comes to buying Champions Oncology's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Champions Oncology are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Champions Current Options Market Mood

Champions Oncology's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Champions Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Champions Oncology's options investors are not very successful. Champions Oncology's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Champions contract

Base on the Rule 16, the options market is currently suggesting that Champions Oncology will have an average daily up or down price movement of about 0.0938% per day over the life of the 2025-05-16 option contract. With Champions Oncology trading at USD 10.28, that is roughly USD 0.009637. If you think that the market is fully incorporating Champions Oncology's daily price movement you should consider buying Champions Oncology options at the current volatility level of 1.5%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Champions Oncology options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Champions calls. Remember, the seller must deliver Champions Oncology stock to the call owner when a call is exercised.

Champions Oncology Option Chain

When Champions Oncology's strike price is surpassing the current stock price, the option contract against Champions Oncology stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Champions Oncology's option chain is a display of a range of information that helps investors for ways to trade options on Champions. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Champions. It also shows strike prices and maturity days for a Champions Oncology against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
CSBR250516C0000250002.56.0 - 9.96.0In
Call
CSBR250516C00005000675.03.9 - 7.53.7In
Call
CSBR250516C00007500377.51.0 - 5.53.52In
Call
CSBR250516C000100009910.01.05 - 3.31.5In
Call
CSBR250516C000125001112.50.0 - 3.81.3Out
Call
CSBR250516C00015000115.00.0 - 4.90.6Out
Call
CSBR250516C00017500017.50.0 - 0.80.8Out
 Put
CSBR250516P0000250002.50.0 - 5.05.0Out
 Put
CSBR250516P00005000125.00.0 - 5.01.25Out
 Put
CSBR250516P00007500197.50.2 - 0.51.25Out
 Put
CSBR250516P00010000010.00.0 - 4.94.9Out
 Put
CSBR250516P00012500012.50.55 - 5.00.55In
 Put
CSBR250516P00015000015.02.5 - 7.02.5In
 Put
CSBR250516P00017500017.55.1 - 9.05.1In

Champions Oncology Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Champions Oncology Market Cap Over Time

   Market Cap   
       Timeline  

Champions Total Stockholder Equity

Total Stockholder Equity

(2.08 Million)

Champions Oncology reported last year Total Stockholder Equity of (2.19 Million)

Champions Oncology Corporate Management

Marianna ZipetoResearch CommercialProfile
Michael MBAChief OfficerProfile
Maria ManciniChief OperationsProfile
Karin HeidemannExecutive OperationsProfile
Arthur HansonVice TechnologyProfile
BS CMAREx OperationsProfile

Additional Tools for Champions Stock Analysis

When running Champions Oncology's price analysis, check to measure Champions Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Champions Oncology is operating at the current time. Most of Champions Oncology's value examination focuses on studying past and present price action to predict the probability of Champions Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Champions Oncology's price. Additionally, you may evaluate how the addition of Champions Oncology to your portfolios can decrease your overall portfolio volatility.